Winston Zapanta Ong

This inventor holds 47 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 6 EPO patents, primarily in Therapeutic Compounds. Top assignees: Kala Pharmaceuticals, Inc., Kata Pharmaceuticals, Inc.. Active years: 2015-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Winston Zapanta Ong. Retrieved from https://idiyas.com/inventor/winston-zapanta-ong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 47 (Patent Applications = 12)

% Patents Active = 53.2

CIPO Patents = 2 (Patent Applications = 9)

EPO Patents = 6 (Patent Applications = 9)

Average Co-Inventor Count = 3.3

ph-index = 5

Forward Citations = 120(Granted Patents)

Location History:

Waltham, MA (US) (2017 - 2020)
Watertown, MA (US) (2020 - 2022)
Stoneham, MA (US) (2015 - 2023)

Company Filing History:

46 out of 53

Kala Pharmaceuticals, Inc.

patents

1 out of 1

Kata Pharmaceuticals, Inc.

patent

Years Active: 2015-2023

Loading Chart...

Areas of Expertise:

Crystalline Forms

Therapeutic Compounds

Urea Derivatives

RET9 Inhibitors

VEGFR2 Inhibitors

Meropenem Derivatives

Biochemical Binding

Angiogenesis

Growth Factors

Pharmaceutical Applications

Compound Uses

Drug Development

47 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11713323 - Crystalline forms of therapeutic compounds and uses thereof (2023-08-01),

2. 11401260 - Biochemical binding of RET9 and VEGFR2 inhibitors (2022-08-02),

3. 11369611 - Therapeutic compounds and uses thereof (2022-06-28),

4. 11352343 - Urea derivatives and uses thereof (2022-06-07),

5. 11104685 - Crystalline forms of therapeutic compounds and uses thereof (2021-08-31),

6. 11091487 - Meropenem derivatives and uses thereof (2021-08-17),

7. 11021487 - Crystalline forms of therapeutic compounds and uses thereof (2021-06-01),

8. 10975090 - Crystalline forms of therapeutic compounds and uses thereof (2021-04-13),

9. 10966987 - Therapeutic compounds and uses thereof (2021-04-06),

10. 10954244 - Compounds and uses thereof (2021-03-23),

11. 10875857 - 1-amino-triazolo(1,5-A)pyridine-substituted urea derivative and uses thereof (2020-12-29),

12. 10766907 - Crystalline forms of therapeutic compounds and uses thereof (2020-09-08),

13. 10758539 - Therapeutic compounds and uses thereof (2020-09-01),

14. 10723719 - Urea derivatives and uses thereof (2020-07-28),

15. 10626121 - Crystalline forms of therapeutic compounds and uses thereof (2020-04-21),

Title: **Winston Zapanta Ong: A Pioneer in Therapeutic Innovations**

Introduction

Winston Zapanta Ong, based in Waltham, MA, is an innovative inventor renowned for his significant contributions to the field of therapeutic compounds. With an impressive portfolio of 47 patents, Ong has dedicated his career to developing advanced pharmaceutical solutions that address various medical challenges.

Latest Patents

Among his notable patents, two stand out for their innovative approaches:

1. **Crystalline Forms of Therapeutic Compounds and Uses Thereof** - This patent describes several crystalline forms of Compound 3, which are employed in pharmaceutical compositions. The invention also includes nanoparticles, particularly mucus penetrating particles (MPPs), that enhance drug delivery. Furthermore, it outlines methods for treating or preventing diseases using these crystalline forms or compositions.

2. **Biochemical Binding of RET9 and VEGFR2 Inhibitors** - This patent presents compounds, compositions, and pharmaceutical formulations of a specific formula aimed at treating various diseases. These include proliferative, ocular, dermatological, inflammatory, autoimmune, and metabolic diseases. The methods outlined utilize these compounds as therapeutics, specifically targeting diseases associated with growth factor activity or angiogenesis.

Career Highlights

Winston Ong has worked with reputable companies such as Kala Pharmaceuticals, Inc. and Kata Pharmaceuticals, Inc. Throughout his career, he has focused on advancing therapeutic innovations that improve patient outcomes and address unmet medical needs.

Collaborations

Ong's professional journey includes collaborations with esteemed colleagues such as Pawel Wojciech Nowak and Jinsoo Kim. Together, they contribute to groundbreaking research and development in the pharmaceutical field, leveraging their expertise to foster innovation.

Conclusion

Winston Zapanta Ong's dedication to creating innovative therapeutic solutions has established him as a significant figure in the realm of pharmaceuticals. His patents not only showcase his inventive spirit but also reflect his commitment to improving healthcare and providing effective treatments for various diseases. The impact of his work continues to resonate within the industry, promising a brighter future for therapeutic advancements.

Profile summary based on public USPTO records.